193 related articles for article (PubMed ID: 34920454)
1. Identification of germline monoallelic mutations in IKZF2 in patients with immune dysregulation.
Shahin T; Mayr D; Shoeb MR; Kuehn HS; Hoeger B; Giuliani S; Gawriyski LM; Petronczki ÖY; Hadjadj J; Bal SK; Zoghi S; Haimel M; Jimenez Heredia R; Boutboul D; Triebwasser MP; Rialland-Battisti F; Costedoat Chalumeau N; Quartier P; Tangye SG; Fleisher TA; Rezaei N; Romberg N; Latour S; Varjosalo M; Halbritter F; Rieux-Laucat F; Castanon I; Rosenzweig SD; Boztug K
Blood Adv; 2022 Apr; 6(7):2444-2451. PubMed ID: 34920454
[TBL] [Abstract][Full Text] [Related]
2. Loss-of-function mutation in
Hetemäki I; Kaustio M; Kinnunen M; Heikkilä N; Keskitalo S; Nowlan K; Miettinen S; Sarkkinen J; Glumoff V; Andersson N; Kettunen K; Vanhanen R; Nurmi K; Eklund KK; Dunkel J; Mäyränpää MI; Schlums H; Arstila TP; Kisand K; Bryceson YT; Peterson P; Otava U; Syrjänen J; Saarela J; Varjosalo M; Kekäläinen E
Sci Immunol; 2021 Nov; 6(65):eabe3454. PubMed ID: 34826260
[TBL] [Abstract][Full Text] [Related]
3. Germline biallelic mutation affecting the transcription factor Helios causes pleiotropic defects of immunity.
Shahin T; Kuehn HS; Shoeb MR; Gawriyski L; Giuliani S; Repiscak P; Hoeger B; Yüce Petronczki Ö; Bal SK; Zoghi S; Dmytrus J; Seruggia D; Castanon I; Rezaei N; Varjosalo M; Halbritter F; Rosenzweig SD; Boztug K
Sci Immunol; 2021 Nov; 6(65):eabe3981. PubMed ID: 34826259
[TBL] [Abstract][Full Text] [Related]
4. IKAROS and AIOLOS directly regulate AP-1 transcriptional complexes and are essential for NK cell development.
Goh W; Sudholz H; Foroutan M; Scheer S; Pfefferle A; Delconte RB; Meng X; Shen Z; Hennessey R; Kong IY; Schuster IS; Andoniou CE; Davis MJ; Hediyeh-Zadeh S; Souza-Fonseca-Guimaraes F; Parish IA; Beavis P; Thiele D; Chopin M; Degli-Esposti MA; Cursons J; Kallies A; Rautela J; Nutt SL; Huntington ND
Nat Immunol; 2024 Feb; 25(2):240-255. PubMed ID: 38182668
[TBL] [Abstract][Full Text] [Related]
5. Abnormal hematopoiesis and autoimmunity in human subjects with germline IKZF1 mutations.
Hoshino A; Okada S; Yoshida K; Nishida N; Okuno Y; Ueno H; Yamashita M; Okano T; Tsumura M; Nishimura S; Sakata S; Kobayashi M; Nakamura H; Kamizono J; Mitsui-Sekinaka K; Ichimura T; Ohga S; Nakazawa Y; Takagi M; Imai K; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S; Kojima S; Nonoyama S; Morio T; Kanegane H
J Allergy Clin Immunol; 2017 Jul; 140(1):223-231. PubMed ID: 27939403
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Aiolos and Ikaros expression by lenalidomide reduces human ILC3-ILC1/NK cell transdifferentiation.
Mazzurana L; Forkel M; Rao A; Van Acker A; Kokkinou E; Ichiya T; Almer S; Höög C; Friberg D; Mjösberg J
Eur J Immunol; 2019 Sep; 49(9):1344-1355. PubMed ID: 31151137
[TBL] [Abstract][Full Text] [Related]
7. CD4
Polak K; Marchal P; Taroni C; Ebel C; Kirstetter P; Kastner P; Chan S
Biochem Biophys Res Commun; 2023 Sep; 674():83-89. PubMed ID: 37413709
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-4772-3p promotes enhanced regulatory T cell capacity in malignant pleural effusion by elevating Helios levels.
Yu WQ; Ji NF; Gu CJ; Sun ZX; Wang ZX; Chen ZQ; Ma Y; Wu ZZ; Wang YL; Wu CJ; Ding MD; Dai GH; Yao J; Jin RR; Huang M; Zhang MS
Chin Med J (Engl); 2019 Nov; 132(22):2705-2715. PubMed ID: 31725455
[TBL] [Abstract][Full Text] [Related]
9. Germline
Kuehn HS; Nunes-Santos CJ; Rosenzweig SD
Expert Rev Clin Immunol; 2021 Apr; 17(4):407-416. PubMed ID: 33691560
[No Abstract] [Full Text] [Related]
10. Dominant negative variants in
Mohajeri A; Vaseghi-Shanjani M; Rosenfeld JA; Yang GX; Lu H; Sharma M; Lin S; Salman A; Waqas M; Sababi Azamian M; Worley KC; Del Bel KL; Kozak FK; Rahmanian R; Biggs CM; Hildebrand KJ; Lalani SR; Nicholas SK; Scott DA; Mostafavi S; van Karnebeek C; Henkelman E; Halparin J; Yang CL; Armstrong L; ; ; Turvey SE; Lehman A
J Med Genet; 2023 Nov; 60(11):1092-1104. PubMed ID: 37316189
[TBL] [Abstract][Full Text] [Related]
11. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency.
Boutboul D; Kuehn HS; Van de Wyngaert Z; Niemela JE; Callebaut I; Stoddard J; Lenoir C; Barlogis V; Farnarier C; Vely F; Yoshida N; Kojima S; Kanegane H; Hoshino A; Hauck F; Lhermitte L; Asnafi V; Roehrs P; Chen S; Verbsky JW; Calvo KR; Husami A; Zhang K; Roberts J; Amrol D; Sleaseman J; Hsu AP; Holland SM; Marsh R; Fischer A; Fleisher TA; Picard C; Latour S; Rosenzweig SD
J Clin Invest; 2018 Jul; 128(7):3071-3087. PubMed ID: 29889099
[TBL] [Abstract][Full Text] [Related]
12. IKAROS-Associated Diseases in 2020: Genotypes, Phenotypes, and Outcomes in Primary Immune Deficiency/Inborn Errors of Immunity.
Kuehn HS; Nunes-Santos CJ; Rosenzweig SD
J Clin Immunol; 2021 Jan; 41(1):1-10. PubMed ID: 33392855
[TBL] [Abstract][Full Text] [Related]
13. AIOLOS Variants Causing Immunodeficiency in Human and Mice.
Yamashita M; Morio T
Front Immunol; 2022; 13():866582. PubMed ID: 35444653
[TBL] [Abstract][Full Text] [Related]
14. Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy.
Bonazzi S; d'Hennezel E; Beckwith REJ; Xu L; Fazal A; Magracheva A; Ramesh R; Cernijenko A; Antonakos B; Bhang HC; Caro RG; Cobb JS; Ornelas E; Ma X; Wartchow CA; Clifton MC; Forseth RR; Fortnam BH; Lu H; Csibi A; Tullai J; Carbonneau S; Thomsen NM; Larrow J; Chie-Leon B; Hainzl D; Gu Y; Lu D; Meyer MJ; Alexander D; Kinyamu-Akunda J; Sabatos-Peyton CA; Dales NA; Zécri FJ; Jain RK; Shulok J; Wang YK; Briner K; Porter JA; Tallarico JA; Engelman JA; Dranoff G; Bradner JE; Visser M; Solomon JM
Cell Chem Biol; 2023 Mar; 30(3):235-247.e12. PubMed ID: 36863346
[TBL] [Abstract][Full Text] [Related]
15. Inborn errors of IKAROS and AIOLOS.
Yamashita M; Morio T
Curr Opin Immunol; 2021 Oct; 72():239-248. PubMed ID: 34265590
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4(CRBN.).
Gandhi AK; Kang J; Havens CG; Conklin T; Ning Y; Wu L; Ito T; Ando H; Waldman MF; Thakurta A; Klippel A; Handa H; Daniel TO; Schafer PH; Chopra R
Br J Haematol; 2014 Mar; 164(6):811-21. PubMed ID: 24328678
[TBL] [Abstract][Full Text] [Related]
17. T and B cell abnormalities, pneumocystis pneumonia, and chronic lymphocytic leukemia associated with an AIOLOS defect in patients.
Kuehn HS; Chang J; Yamashita M; Niemela JE; Zou C; Okuyama K; Harada J; Stoddard JL; Nunes-Santos CJ; Boast B; Baxter RM; Hsieh EWY; Garofalo M; Fleisher TA; Morio T; Taniuchi I; Dutmer CM; Rosenzweig SD
J Exp Med; 2021 Dec; 218(12):. PubMed ID: 34694366
[TBL] [Abstract][Full Text] [Related]
18. Inborn errors of human IKAROS: LOF and GOF variants associated with primary immunodeficiency.
Kuehn HS; Boast B; Rosenzweig SD
Clin Exp Immunol; 2023 Apr; 212(2):129-136. PubMed ID: 36433803
[TBL] [Abstract][Full Text] [Related]
19. AIOLOS-Associated Inborn Errors of Immunity.
Yamashita M; Morio T
J Clin Immunol; 2024 May; 44(6):128. PubMed ID: 38773004
[TBL] [Abstract][Full Text] [Related]
20. Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus.
Alexander T; Sattler A; Templin L; Kohler S; Groß C; Meisel A; Sawitzki B; Burmester GR; Arnold R; Radbruch A; Thiel A; Hiepe F
Ann Rheum Dis; 2013 Sep; 72(9):1549-58. PubMed ID: 23264341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
